News
VRT benefits from AI-driven demand with strong Q2 growth expected, but stretched valuation may give investors pause ahead of earnings.
StockStory.org on MSN14h
Crocs (CROX): Buy, Sell, or Hold Post Q1 Earnings?
Crocs has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has ...
StockStory.org on MSN14h
Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?
Over the last six months, Zoetis’s shares have sunk to $153.39, producing a disappointing 11.4% loss - a stark contrast to ...
Nvidia completed its 10-for-1 stock split on June 7 of last year, with shares trading at the split-adjusted price as of June ...
First, let's just look at the simple chart for Nvidia (NVDA). The stock's old high at $153 (red bar) should provide support. The 40% downturn that occurred in the first four months of 2025 is history.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Nvidia has been an artificial intelligence leader and major winner over the past few years. On July 16, CEO Jensen Huang may ...
Nvidia’s valuation is stretched after a huge run, with overbought technicals and fading margin of safety. Check out why NVDA ...
Two prominent hedge fund managers sold Nvidia and bought Palantir in the first quarter. Nvidia has shaken off concerns about DeepSeek, and its stock trades at a reasonable valuation, compared to ...
The CBA might be the world's most expensive bank, but momentum makes for a compelling reason to hold the stock as well ...
BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock? June 30, 2025 — 09:50 am EDT Written by Ekta Bagri for Zacks -> The first half of 2025 has been topsy-turvy for Bristol Myers BMY.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results